Gastrointestinal Endoscopic Device Market Size, Share & Trends Analysis | Global | 2025-2032 | Includes: GI Endoscopes, Capsule Endoscopy, Stenting and Dilation Devices, and 7 more

Description

List of Tables

The global gastrointestinal endoscopic device market was valued at nearly $16.3 billion in 2025. It is expected to grow at a compound annual growth rate of 4.0 percent to reach over $21.5 billion by 2031.

This report covers GI endoscopes, capsule endoscopy, stenting and dilation devices, ERCP devices, biopsy forceps and polypectomy snares, EUS needles, endoscopic submucosal dissection (ESD) knives, hemostasis devices, enteral feeding devices, and anti-reflux devices. The study quantifies unit sales, average selling prices (ASPs), market size, growth rates, and company shares, and analyzes procedure volumes, growth drivers and limiters, recent mergers and acquisitions, product portfolios, and competitive dynamics. Forecasts extend to 2031 with historical data to 2021.

Growth is supported by rising screening and early detection programs, an aging global population, and technology upgrades across imaging, therapeutic accessories, and single-use platforms. As emerging regions expand healthcare access, procedure volumes are expected to increase across diagnostic colonoscopy, ERCP, EUS, and therapeutic GI interventions.

Market Overview

Gastrointestinal endoscopy is central to the detection and treatment of GI disease. Colonoscopy is the anchor procedure for colorectal cancer screening and polyp removal, while upper GI endoscopy addresses bleeding, strictures, and reflux-related pathology. Therapeutic procedures such as ERCP, ESD, and EUS-guided interventions have broadened the role of endoscopy beyond diagnosis to include complex therapy.

Market value is shaped by a mix of capital equipment, reusable and single-use devices, and high-volume consumables. The capital base includes GI endoscopes and video processors. High-throughput categories such as biopsy forceps, polypectomy snares, stents, balloons, and hemostasis tools drive recurring revenue. Capsule endoscopy adds a non-invasive pathway for small bowel imaging, while enteral feeding devices support nutrition management in acute and chronic care.

Providers are upgrading from standard imaging to HD and HD+, with selective adoption of 4K and magnification where budgets allow. Single-use endoscopes are gaining attention for infection control and workflow advantages in targeted settings. At the same time, structured national screening programs are expanding the population that enters GI care pathways, which supports steady procedure growth.

Cost control remains a defining factor. Group purchasing organizations and tender models reduce ASPs in mature markets, while hospital budgets drive staged adoption of single-use devices. Even so, demand for advanced therapy has continued to expand as clinicians pursue less invasive alternatives to open surgery and as evidence for endoscopic therapy grows.

Emerging regions in Asia-Pacific and Latin America are set to contribute a larger share of global volumes as infrastructure improves, training expands, and public awareness increases. In these markets, growth in endoscopy suites and imaging fleets will support both diagnostic and therapeutic procedures.

Market Drivers

Incidence of cancer

Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related death. Aging demographics and better awareness drive more people into screening programs. Colonoscopy every five to ten years allows the detection and removal of precancerous polyps, which lowers cancer risk. Rising participation in screening supports sustained demand for colonoscopes, biopsy tools, snares, and hemostasis devices.

Screening and early detection programs

Policy changes and national programs have widened the eligible screening population. In the United States, the USPSTF lowered the recommended starting age for colorectal screening from 50 to 45 years, which increases the number of screening colonoscopies. The U.K. NHS is reducing the starting age for bowel screening from 60 to 50. In South Korea, the national program uses biennial FIT with colonoscopy follow-up for positive tests. These programs create predictable, recurring volumes that support stable purchasing of scopes and consumables, and they drive adoption of higher-performance imaging to improve polyp detection.

New technological developments

Imaging upgrades to HD and HD+, along with magnification and better optics, improve diagnostic accuracy. Flexible scopes have become easier to maneuver, and specialized accessories allow more precise therapy. Single-use platforms reduce cross-contamination risk and simplify reprocessing, which can be valuable for infection control and staffing constraints. Notable products include Boston Scientific's Exalt Model D single-use duodenoscope and Ambu's aScope portfolio. In parallel, 3D visualization and 4K imaging are being evaluated for specific use cases. As these technologies mature and cost barriers decline, unit sales and procedure counts are expected to rise.

Expansion in emerging regions

Healthcare investment in Asia-Pacific and Latin America is increasing the number of endoscopy suites, training programs, and referral pathways. Urbanization and higher incomes improve access to care. As awareness of GI disease rises and screening becomes more common, procedure volumes increase, lifting demand for endoscopes, ERCP devices, EUS needles, and hemostasis tools.

Therapeutic breadth and efficiency

Endoscopy now treats bleeding, removes stones, dilates strictures, resects early cancers, and closes defects. Broader therapy expands the addressable market beyond screening and diagnosis. Efficiency gains through AI-assisted polyp detection, improved hemostasis devices, and faster ERCP stone-management tools shorten procedure time and improve throughput, which supports adoption.

Market Limiters

Group purchasing organizations

GPOs and tenders consolidate demand and push down prices, which makes it difficult for smaller manufacturers to compete. Volume commitments and aggressive discounts favor large vendors with broad portfolios. This dynamic limits the market access of niche players and compresses ASPs, particularly in high-volume consumables.

Screening alternatives

Less invasive screening methods such as FIT-DNA, blood-based tests, and capsule colonoscopy are gaining interest. These options can reduce barriers to initial screening. However, a positive result still requires a colonoscopy for confirmation and treatment, which preserves the central role of endoscopy. Even with some diversion of initial tests, downstream colonoscopy volumes remain necessary, which helps limit the impact on colonoscope unit sales.

Hesitation to adopt new technology

Clinician adoption of new devices is cautious. Many providers seek robust evidence of clinical benefit and workflow fit before changing practice. Cost and training time also slow uptake. Single-use platforms, for example, must justify expense with infection control or efficiency benefits. Over time, favorable studies and better procurement models can stimulate adoption, but the path is gradual.

Budget constraints and reprocessing investments

Hospitals with recent investments in reprocessing and capital fleets will require clear value cases to switch to single-use devices or premium accessories. Budgets in emerging regions prioritize high-impact items first, which can delay adoption of advanced imaging or specialty tools.

Market Coverage and Data Scope

Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that shape demand.
Time frame: Base year 2025, forecasts to 2031, historical data from 2021 to 2024.
Data sources: Primary interviews with industry leaders, government physician and regulatory data, hospital and private practice inputs, import and export records, and the iData Research internal database.
Method note: Revenue is modeled as units multiplied by ASP, validated against procedure volumes, utilization patterns, and installed base assumptions

Care settings include hospitals, outpatient endoscopy centers, ambulatory surgery centers, and specialty clinics.

Markets Covered and Segmentation

Gastrointestinal Endoscope Market

Device type: Reusable, single-use

Capsule Endoscopy Market

Device type: Camera capsule, data recorder

Stenting and Dilation Market

Device type: Esophageal stent, duodenal stent, colonic stent, esophageal dilation balloon, duodenal dilation balloon, colonic dilation balloon

Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market

Device type: Sphincterotome, biliary stone removal balloon, biliary stone removal basket, biliary dilation balloon, biliary and pancreatic stent, biliary lithotripter, ERCP guidewire, ERCP cannula

Biopsy Forceps and Polypectomy Snares Market

Device type: Biopsy forceps, polypectomy snare

EUS Needle Market

Device type: Fine needle aspiration, fine needle biopsy

Endoscopic Submucosal Dissection Knife Market

Hemostasis Device Market

Device type: Hemostasis probe, ligation device, sclerotherapy needle

Enteral Feeding Device Market

Device type: Enteral feeding pump, enteral feeding set, enteral feeding tube

Anti-Reflux Device Market

Each segment is analyzed for market values, ASPs, units, growth rates, and company shares with historical trends and forecast outlook to 2031.

Competitive Analysis

Olympus held the leading position in the GI endoscope market and in the ESD knife segment. The company also maintained strong shares in capsule endoscopy, ERCP devices, biopsy forceps, polypectomy snares, EUS needles, and hemostasis devices. This breadth secured the top overall market share. Olympus continues to benefit from a reputation for durable image quality, a large installed base, and comprehensive service and training support.

Boston Scientific led more accessory segments than any other competitor in 2025. The company held the top share in stenting and dilation devices, ERCP devices, biopsy forceps and polypectomy snares, EUS needles, and hemostasis devices, and it maintained a competitive position in ESD knives. Growth is supported by the AXIOS(TM) lumen-apposing stent for transluminal drainage and by the Exalt Model D single-use duodenoscope, which addresses reprocessing challenges in ERCP. These products help drive procedure efficiency and infection control, supporting continued adoption.

Fujifilm ranked third overall, supported by the second-largest share of the GI endoscope market. Strong imaging capabilities, product reliability, and a growing therapeutic accessory portfolio have advanced its standing in hospitals and outpatient centers. The company placed just ahead of Avanos Medical in total share.

Other participants compete across select niches such as capsule endoscopy, enteral feeding, and anti-reflux devices. In price-sensitive regions, local manufacturers supply value-oriented consumables, while global leaders retain advantages in imaging, training, and full-line service.

Technology and Practice Trends

Imaging upgrades: Adoption of HD and HD+ imaging improves polyp detection and diagnostic accuracy. Selected centers are moving to 4K and magnification for specific use cases.
Single-use endoscopes: Targeted use of single-use duodenoscopes and other scopes can simplify reprocessing and reduce cross-contamination risk. Cost remains the key hurdle to broad adoption.
Therapeutic efficiency: Faster hemostasis modalities, advanced snares, and improved stone-management tools shorten procedure times and standardize workflows.
EUS and ESD growth: EUS needles and ESD knives expand minimally invasive therapy for submucosal lesions and early cancers, which increases accessory consumption per case.
AI assistance: Early use of AI for polyp detection and quality metrics is improving lesion recognition and may help standardize performance across providers.
Capsule endoscopy: Camera capsules offer non-invasive evaluation of the small bowel and can support triage in selected colon investigations, with data recorders enabling streamlined workflows.
Enteral feeding pathways: Pumps, sets, and tubes remain steady sources of recurring revenue in acute and chronic nutrition support.
Anti-reflux devices: Select centers are evaluating implant-based anti-reflux options as alternatives to medical therapy or surgery, which adds to the mix of GI therapeutic tools.

These trends support higher throughput, more consistent outcomes, and a broader range of treatable conditions within the endoscopy suite.

Geography

This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

Where are the largest and fastest-growing opportunities within the GI endoscopic device market.

How screening programs and aging demographics will shape demand for colonoscopy and therapeutic endoscopy.

Which technology upgrades will gain share, including single-use platforms, AI-assisted tools, and advanced imaging.

How GPOs and tender models affect pricing and market access for both large and small manufacturers.

What procedure shifts are expected across ERCP, EUS, ESD, and capsule endoscopy, and how these affect accessory consumption.

How Olympus, Boston Scientific, and Fujifilm are positioned across capital and accessory segments.

What risks could slow adoption, including budget limits, screening alternatives, and clinician hesitancy.

How suppliers can align training, service, and inventory to support growth in emerging regions.

The Global Gastrointestinal Endoscopic Device Market Report from iData Research answers these questions with procedure-aware models, pricing detail, and company share analysis. Use it to quantify demand by category, plan product roadmaps, set pricing and contracting targets, and prioritize training and support programs that speed adoption.

Product Code: iDATA_GLGI26_MS

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Global Gastrointestinal Endoscopic Device Market Overview

Competitive Analysis

Emerging Markets And Technologies

Market Trends

Market Developments

Procedure Segmentation

Market Segmentation

Regions Included

Key Report Updates

Version History

Research Methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Global Gastrointestinal Endoscopic Device Market Overview

3.1 Introduction
3.2 Market Overview & Trend Analysis
- 3.2.1 By Segment
- 3.2.2 By Region
3.3 Drivers And Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers And Acquisitions

Gastrointestinal Endoscope Market

4.1 Executive Summary
- 4.1.1 Global Gastrointestinal Endoscope Market Overview
- 4.1.2 Competitive Analysis
- 4.1.3 Procedure Segmentation
- 4.1.4 Market Segmentation
- 4.1.5 Regions Included
4.2 Introduction
4.3 Procedure Numbers
- 4.3.1 Total Gastrointestinal Endoscopy Procedures
- 4.3.2 Upper Gi (Ugi/Egd) Procedures
- 4.3.3 Colonoscopy Procedures
- 4.3.4 Enteroscopy Procedures
- 4.3.5 Ultrasound Endoscopy Procedures
4.4 Market Overview
- 4.4.1 By Segment
- 4.4.2 By Region
4.5 Market Analysis And Forecast
- 4.5.1 Reusable Gastrointestinal Endoscope Market
  - 4.5.1.1 New Units Reusable Gastrointestinal Endoscope Market
  - 4.5.1.2 Reusable Gastrointestinal Endoscope Service Market
- 4.5.2 Reusable Gastrointestinal Endoscope Market
  - 4.5.2.1 Colonoscope Market
  - 4.5.2.1.1 New Units Reusable Colonoscope Market
  - 4.5.2.1.2 Reusable Colonoscope Service Market
  - 4.5.2.2 Duodenoscope Market
  - 4.5.2.2.1 New Units Reusable Duodenoscope Market
  - 4.5.2.2.2 Reusable Duodenoscope Service Market
  - 4.5.2.3 Enteroscope Market
  - 4.5.2.3.1 New Units Reusable Enteroscope Market
  - 4.5.2.3.2 Reusable Enteroscope Service Market
  - 4.5.2.4 Ultrasound Endoscope Market
  - 4.5.2.4.1 New Units Reusable Ultrasound Endoscope Market
  - 4.5.2.4.2 Reusable Ultrasound Endoscope Service Market
  - 4.5.2.5 Gastroscope Market
  - 4.5.2.5.1 New Units Reusable Ultrasound Endoscope Market
  - 4.5.2.5.2 Reusable Gastroscope Service Market
- 4.5.3 Single-Use Gastrointestinal Endoscope Market
  - 4.5.3.1 Duodenoscope Market
  - 4.5.3.2 Cholangioscope Market
  - 4.5.3.3 Gastroscope Market
  - 4.5.3.4 Choledochoscope Market
4.6 Drivers And Limiters
- 4.6.1 Market Drivers
- 4.6.2 Market Limiters
4.7 Competitive Market Share Analysis

Capsule Endoscopy Market

5.1 Executive Summary
- 5.1.1 Global Capsule Endoscopy Market Overview
- 5.1.2 Competitive Analysis
- 5.1.3 Regions Included
5.2 Introduction
5.3 Procedure Numbers
5.4 Market Overview
- 5.4.1 By Segment
- 5.4.2 By Region
5.5 Market Analysis And Forecast
- 5.5.1 Total Capsule Endoscopy Market
- 5.5.2 Camera Capsule Market
- 5.5.3 Data Recorder Market
5.6 Drivers And Limiters
- 5.6.1 Market Drivers
- 5.6.2 Market Limiters
5.7 Competitive Market Share Analysis

Stenting & Dilation Market

6.1 Executive Summary
- 6.1.1 Global Stenting & Dilation Market Overview
- 6.1.2 Competitive Analysis
- 6.1.3 Procedure Segmentation
- 6.1.4 Market Segmentation
- 6.1.5 Regions Included
6.2 Introduction
6.3 Procedure Numbers
- 6.3.1 Stenting Procedures
  - 6.3.1.1 Esophageal Stenting Procedures
  - 6.3.1.2 Duodenal Stenting Procedures
  - 6.3.1.3 Colonic Stenting Procedures
- 6.3.2 Dilation Procedures
  - 6.3.2.1 Esophageal Dilation Procedures
  - 6.3.2.2 Duodenal Dilation Procedures
  - 6.3.2.3 Colonic Dilation Procedures
6.4 Market Overview
- 6.4.1 By Segment
- 6.4.2 By Region
6.5 Market Analysis And Forecast
- 6.5.1 Total Stenting & Dilation Market
- 6.5.2 Esophageal Stent Market
  - 6.5.2.1 Covered-Metal Esophageal Stent Market
  - 6.5.2.2 Bare-Metal Esophageal Stent Market
  - 6.5.2.3 Plastic Esophageal Stent Market
- 6.5.3 Duodenal Stent Market
- 6.5.4 Colonic Stent Market
- 6.5.5 Esophageal Dilation Balloon Market
- 6.5.6 Duodenal Dilation Balloon Market
- 6.5.7 Colonic Dilation Balloon Market
6.6 Drivers And Limiters
- 6.6.1 Market Drivers
- 6.6.2 Market Limiters
6.7 Competitive Market Share Analysis

Endoscopic Retrograde Cholangiopancreatography Device Market

7.1 Executive Summary
- 7.1.1 Global Endoscopic Retrograde Cholangiopancreatography Device Market Overview
- 7.1.2 Competitive Analysis
- 7.1.3 Procedure Segmentation
- 7.1.4 Market Segmentation
- 7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.4 Market Overview
- 7.4.1 By Segment
- 7.4.2 By Region
7.5 Market Analysis And Forecast
- 7.5.1 Total Endoscopic Retrograde Cholangiopancreatography (Ercp) Device Market
- 7.5.2 Sphincterotome Market
- 7.5.3 Biliary Stone Removal Balloon Market
- 7.5.4 Biliary Stone Removal Basket Market
- 7.5.5 Biliary Dilation Balloon Market
- 7.5.6 Biliary And Pancreatic Stent Market
  - 7.5.6.1 Covered-Metal Biliary And Pancreatic Stent Market
  - 7.5.6.2 Bare-Metal Biliary And Pancreatic Stent Market
  - 7.5.6.3 Plastic Biliary And Pancreatic Stent Market
- 7.5.7 Biliary Lithotripter Market
- 7.5.8 Ercp Guidewire Market
- 7.5.9 Ercp Cannula Market
7.6 Drivers And Limiters
- 7.6.1 Market Drivers
- 7.6.2 Market Limiters
7.7 Competitive Market Share Analysis

Biopsy Forceps And Polypectomy Snares Market

8.1 Executive Summary
- 8.1.1 Global Biopsy Forceps & Polypectomy Snares Market Overview
- 8.1.2 Competitive Analysis
- 8.1.3 Procedure Segmentation
- 8.1.4 Market Segmentation
- 8.1.5 Regions Included
8.2 Introduction
8.3 Procedure Numbers
- 8.3.1 Total Tissue Biopsy Procedures
- 8.3.2 Biopsy Forceps Procedures
- 8.3.3 Polypectomy Snare Procedures
8.4 Market Overview
- 8.4.1 By Segment
- 8.4.2 By Region
8.5 Market Analysis And Forecast
- 8.5.1 Total Biopsy Forceps And Polypectomy Snares Market
- 8.5.2 Biopsy Forceps Market
- 8.5.3 Polypectomy Snare Market
8.6 Drivers And Limiters
- 8.6.1 Market Drivers
- 8.6.2 Market Limiters
8.7 Competitive Market Share Analysis

Eus Needle Market

9.1 Executive Summary
- 9.1.1 Global Eus Needle Market Overview
- 9.1.2 Competitive Analysis
- 9.1.3 Procedure Segmentation
- 9.1.4 Market Segmentation
- 9.1.5 Regions Included
9.2 Introduction
9.3 Procedure Numbers
9.4 Market Overview
- 9.4.1 By Segment
- 9.4.2 By Region
9.5 Market Analysis And Forecast
- 9.5.1 Fine Needle Aspiration Market
- 9.5.2 Fine Needle Biopsy Market
9.6 Drivers And Limiters
- 9.6.1 Market Drivers
- 9.6.2 Market Limiters
9.7 Competitive Market Share Analysis